LEP and breast carcinoma: We show that HNK effectively inhibits leptin-induced growth of breast cancer cells in vitro and in vivo. Importantly, oral HNK treatment also efficiently abrogates breast tumor growth in HFD-induced obese-hyperleptinemic mice.